UnknownNot Applicable

Analysis of Gene Expression in Femoroacetabular Impingement (FAI)

China100 participantsStarted 2021-03-30

Plain-language summary

Femoral acetabular impingement (FAI) is a common disease of the hip joint. In this study, whole-genome sequencing was used to further explore the pathogenesis of this disease.

Who can participate

Age range15 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * The patient underwent preoperative imaging and was diagnosed with FAI. The patient complained of pain in the hip, hip, or thigh, and had a positive hip flexion impact test. Exclusion Criteria: * Patients with hip surgery history, hip osteoarthritis, necrosis of the femoral head, hip infection, hip dysplasia and other hip diseases.

What they're measuring

The patients were clinically diagnosed with FAI (femoral acetabular impingement) and underwent arthroscopic surgery, then clinical samples were collected.

Timeframe: The patient was diagnosed with FAI, and conservative treatment was ineffective for an average of 6 months.

Trial details

NCT IDNCT04988659

SponsorPeking University Third Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2021-05-30

View on ClinicalTrials.gov More Femoroacetabular Impingement trials